Stelzer Laurie's Form 4 filing
Mirati Therapeutics, Inc. (MRTX) · filed Jun 2, 2023
- Accession no.
- 0001628280-23-020720
- Filed
- Jun 2, 2023
- Trade date
- Jun 2, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $172.2K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Stelzer LaurieCIK 0001644348 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2023 | Common Stock | SSaleDisposed | −4,647 | $37.06 | −$172,217.82 | 80,015 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.